HIV Screening Among Gonorrhea-Diagnosed Individuals; Baltimore, Maryland; April 2015 to April 2019.
Journal
Sexually transmitted diseases
ISSN: 1537-4521
Titre abrégé: Sex Transm Dis
Pays: United States
ID NLM: 7705941
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
entrez:
15
12
2020
pubmed:
16
12
2020
medline:
25
5
2021
Statut:
ppublish
Résumé
Individuals diagnosed with gonorrhea are at elevated risk for HIV. Per US Centers for Disease Control and Prevention guideline, individuals being evaluated for gonorrhea should be screened for HIV concurrently. There is limited information on HIV screening among gonorrhea-diagnosed individuals across different health care settings. Our objective was to identify potential gaps in HIV screening among gonorrhea-diagnosed individuals in Baltimore City, Maryland. We used Sexually Transmitted Disease Surveillance Network project data collected on a random sample of all gonorrhea diagnoses reported to the health department between April 2015 and April 2019. Individuals with known HIV diagnoses were excluded. HIV screening was confirmed through surveys administered to the gonorrhea-diagnosing provider. HIV screening across groups was assessed using Poisson regression models with robust SEs. We examined those with and without recent (≤12 months) sexually transmitted infection (STI) history separately. Among 2830 gonorrhea-diagnosed individuals with completed Sexually Transmitted Disease Surveillance Network provider surveys, less than half (35.2% with and 44.8% without recent STI history) received concurrent HIV screening. HIV screening was 73% less prevalent among those diagnosed in emergency departments/urgent care centers/hospitals versus sexual health clinics (with and without recent STI history: adjusted prevalence ratio, 0.27 [95% confidence interval, 0.19-0.39]; adjusted prevalence ratio, 0.27 [0.23-0.33]), controlling for diagnosis year, sex, race/ethnicity, age, infection site, and insurance. Our findings suggest a considerable gap in HIV screening among individuals at elevated risk for HIV acquisition in Baltimore City, particularly among those diagnosed in emergency departments/urgent care centers/hospital settings. Future work should focus on identifying provider-level barriers to concurrent HIV/STI screening to inform provider education programs.
Sections du résumé
BACKGROUND
Individuals diagnosed with gonorrhea are at elevated risk for HIV. Per US Centers for Disease Control and Prevention guideline, individuals being evaluated for gonorrhea should be screened for HIV concurrently. There is limited information on HIV screening among gonorrhea-diagnosed individuals across different health care settings. Our objective was to identify potential gaps in HIV screening among gonorrhea-diagnosed individuals in Baltimore City, Maryland.
METHODS
We used Sexually Transmitted Disease Surveillance Network project data collected on a random sample of all gonorrhea diagnoses reported to the health department between April 2015 and April 2019. Individuals with known HIV diagnoses were excluded. HIV screening was confirmed through surveys administered to the gonorrhea-diagnosing provider. HIV screening across groups was assessed using Poisson regression models with robust SEs. We examined those with and without recent (≤12 months) sexually transmitted infection (STI) history separately.
RESULTS
Among 2830 gonorrhea-diagnosed individuals with completed Sexually Transmitted Disease Surveillance Network provider surveys, less than half (35.2% with and 44.8% without recent STI history) received concurrent HIV screening. HIV screening was 73% less prevalent among those diagnosed in emergency departments/urgent care centers/hospitals versus sexual health clinics (with and without recent STI history: adjusted prevalence ratio, 0.27 [95% confidence interval, 0.19-0.39]; adjusted prevalence ratio, 0.27 [0.23-0.33]), controlling for diagnosis year, sex, race/ethnicity, age, infection site, and insurance.
CONCLUSIONS
Our findings suggest a considerable gap in HIV screening among individuals at elevated risk for HIV acquisition in Baltimore City, particularly among those diagnosed in emergency departments/urgent care centers/hospital settings. Future work should focus on identifying provider-level barriers to concurrent HIV/STI screening to inform provider education programs.
Identifiants
pubmed: 33319970
doi: 10.1097/OLQ.0000000000001252
pii: 00007435-202101000-00008
doi:
Types de publication
Journal Article
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
42-48Références
Fonner VA, Dalglish SL, Kennedy CE, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS 2016; 30:1973–1983.
Centers for Disease Control and Prevention. HIV Surveillance Report 2017. Atlanta, GA: CDC, 2018.
Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2016. HIV Surveill Suppl Rep 2019; 24: (No. 1). Available at: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html . Published February 2019. Accessed April 7, 2020.
Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19:61–77.
Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3–17.
Zetola NM, Bernstein KT, Wong E, et al. Exploring the relationship between sexually transmitted diseases and HIV acquisition by using different study designs. J Acquir Immune Defic Syndr 2009; 50:546–551.
Bernstein KT, Marcus JL, Nieri G, et al. Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion. J Acquir Immune Defic Syndr 2010; 53:537–543.
Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64:1–137.
Centers for Disease Control and Prevention: US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: a clinical practice guideline. Available at: https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf . Published March 2018.
Weinstock H, Dale M, Linley L, et al. Unrecognized HIV infection among patients attending sexually transmitted disease clinics. Am J Public Health 2002; 92:280–283.
Traynor SM, Rosen-Metsch L, Feaster DJ. Missed opportunities for HIV testing among STD clinic patients. J Community Health 2018; 43:1128–1136.
Tao G, Zhang CX. HIV testing of commercially insured patients diagnosed with sexually transmitted diseases. Sex Transm Dis 2008; 35:43–46.
Chen JY, Ma Q, Everhard F, et al. HIV screening in commercially insured patients screened or diagnosed with sexually transmitted diseases or blood-borne pathogens. Sex Transm Dis 2011; 38:522–527.
Adekeye OA, Abara WE, Xu J, et al. HIV screening rates among Medicaid enrollees diagnosed with other sexually transmitted infections. PLoS One 2016; 11:e0161560.
Kwan CK, Rose CE, Brooks JT, et al. HIV testing among men at risk for acquiring HIV infection before and after the 2006 CDC recommendations. Public Health Rep 2016; 131:311–319.
Bradley H, Asbel L, Bernstein K, et al. HIV testing among patients infected with Neisseria gonorrhoeae : STD Surveillance Network, United States, 2009–2010. AIDS Behav 2013; 17:1205–1210.
Centers for Disease Control and Prevention. HIV Surveillance Report. 2017; 29. Available at: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html . Published November 2018. Accessed November 18, 2019.
Baltimore City Annual HIV Epidemiological Profile 2017. Center for HIV Surveillance, Epidemiology and Evaluation. Baltimore, MD: Maryland Department of Health:2018.
Tilchin C, Schumacher CM, Psoter KJ, et al. Human immunodeficiency virus diagnosis after a syphilis, gonorrhea, or repeat diagnosis among males including non-men who have sex with men: What is the incidence?Sex Transm Dis 2019; 46:271–277.
CDC-RFA-PS13-1306, STD Surveillance Network. Available at: http://www.cdc.gov/std/ssun/default.htm .
Van Handel M, Kann L, Olsen EO, et al. HIV testing among US high school students and young adults. Pediatrics 2016; 137:e20152700.
Mahajan AP, Stemple L, Shapiro MF, et al. Consistency of state statutes with the Centers for Disease Control and Prevention HIV testing recommendations for health care settings. Ann Intern Med 2009; 150:263–269.
Mehta AS, Goyal MK, Dowshen N, et al. Practices, beliefs, and perceived barriers to adolescent human immunodeficiency virus screening in the emergency department. Pediatr Emerg Care 2015; 31:621–626.
Safi AG, Perin J, Mantsios A, et al. Public health detailing to increase routine HIV screening in Baltimore, Maryland: Satisfaction, feasibility, and effectiveness. Public Health Rep 2017; 132:609–616.
Baltimore City Annual HIV Epidemiological Profile. Center for HIV Surveillance, Epidemiology and Evaluation. Baltimore, MD: Maryland Department of Health, 2018:2019.
Freeman AE, Sattin RW, Miller KM, et al. Acceptance of rapid HIV screening in a southeastern emergency department. Acad Emerg Med 2009; 16:1156–1164.
Gebrezgi MT, Mauck DE, Sheehan DM, et al. Acceptance of opt-out HIV screening in outpatient settings in the United States: A systematic review and meta-analysis. Public Health Rep 2019; 134:484–492.
Mutebi CM, Foster B, Foley D, et al. Acceptance of rapid human immunodeficiency virus testing in an urban emergency department. J Community Health 2019; 45:728–731.